ArticleInternational journal of computer assisted radiology and surgery2021
High-quality chest CT segmentation to assess the impact of COVID-19 disease.
Article in International journal of computer assisted radiology and surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Robust Medical Diagnosis: A Novel Two-Phase Deep Learning Framework for Adversarial Proof Disease Detection in Radiology Images.Journal of imaging informatics in medicine · 2024Article
- COVID-19 detection based on self-supervised transfer learning using chest X-ray images.International journal of computer assisted radiology and surgery · 2023Article
- Research on the Application of Artificial Intelligence in Public Health Management: Leveraging Artificial Intelligence to Improve COVID-19 CT Image Diagnosis.International journal of environmental research and public health · 2023Article
- Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center.Journal of personalized medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCOVID-19 has spread rapidly worldwide since its initial appearance, creating the need for faster diagnostic methods and tools. Due to the high rate of false-negative RT-PCR tests, the role of chest CT examination has been investigated as an auxiliary procedure. The main goal of this work is to establish a well-defined strategy for 3D segmentation of the airways and lungs of COVID-19 positive patients from CT scans, including detected abnormalities. Their identification and the volumetric quantification could allow an easier classification in terms of gravity, extent and progression of the infection. Moreover, these 3D reconstructions can provide a high-impact tool to enhance awareness of the severity of COVID-19 pneumonia.
methodsSegmentation process was performed utilizing a proprietary software, starting from six different stacks of chest CT images of subjects with and without COVID-19. In this context, a comparison between manual and automatic segmentation methods of the respiratory system was conducted, to assess the potential value of both techniques, in terms of time consumption, required anatomical knowledge and branch detection, in healthy and pathological conditions.
resultsHigh-quality 3D models were obtained. They can be utilized to assess the impact of the pathology, by volumetrically quantifying the extension of the affected areas. Indeed, based on the obtained reconstructions, an attempted classification for each patient in terms of the severity of the COVID-19 infection has been outlined.
conclusionsAutomatic algorithms allowed for a substantial reduction in segmentation time. However, a great effort was required for the manual identification of COVID-19 CT manifestations. The developed automated procedure succeeded in obtaining sufficiently accurate models of the airways and the lungs of both healthy patients and subjects with confirmed COVID-19, in a reasonable time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.